Telomere shortening is associated with age and risk of medical comorbidity. We assessed the relationship between measures of adiposity, leukocyte telomere length, and mortality and whether it is modified by age. SUBJECTS/METHODS: Subjects with dual-energy X-ray absorptiometry measures were identified using the National Health and Nutrition Examination Survey 1999-2002. Obesity was categorized using two body fat definitions (BF1%: men ⩾ 25%; females ⩾ 35%; BF2% ⩾ 28% and ⩾ 38%, respectively), body mass index (BMI) and waist circumference (WC; men ⩾ 102 cm; females ⩾ 88 cm). Telomere length relative to standard reference DNA (T/S ratio) was assessed using quantitative PCR. Weighted multivariable regression models evaluated the association of telomere length with adiposity, both continuously and categorically (low/normal BF%, low/high WC and standard BMI categories). Differences in telomere length by age and adiposity were ascertained and subsequent models were stratified by age. Proportional hazard models assessed the risk of mortality by adiposity status. A telomere by adiposity interaction was tested in the entire cohort and by age category ( o60 vs ⩾ 60 years; o 70 vs ⩾ 70 years). RESULTS: We identified 7827 subjects. Mean age was 46.1 years. Overall telomere length was 1.05 ± 0.01 (s.e.) that differed by BF1% (low/high: 1.12 ± 0.02 vs 1.03 ± 0.02; P o0.001), BF2% (1.02 ± 0.02 vs 1.11 ± 0.02; P o0.001), BMI (underweight 1.08 ± 0.03; normal 1.09 ± 0.02; overweight 1.04 ± 0.02; and obese 1.03 ± 0.02;P o 0.001) and WC (low/high 1.09 ± 0.02 vs 1.02 ± 0.02; Po 0.001). Adjusted β-coefficients evaluating the relationship between telomere length and adiposity (measured continuously) were as follows: BF1% (β = − 0.0033 ± 0.0008; P o 0.001), BF2% (−0.041 ± 0.008; P o0.001), BMI (β = − 0.025 ± 0.0008; P = 0.005) and WC (β = − 0.0011 ± 0.0004; P = 0.007). High BF% (BF1%: β = − 0.035 ± 0.011; P = 0.002; BF2%: β = − 0.041 ± 0.008; P o 0.001) and WC (β = − 0.035 ± 0.011; P = 0.008) were inversely related to telomere length (TL). Stratifying by age, high BF1% (−0.061 ± 0.013), BF2% (−0.065 ± 0.01), BMI-obesity (−0.07 ± 0.015) and high WC (−0.048 ± 0.013) were significant (all P o 0.001). This association diminished with increasing age. In older participants, TL was inversely related to mortality (hazard ratio 0.36 (0.27, 0.49)), as were those classified by BF1% (0.68 (0.56, 0.81)), BF2% (0.75 (0.65, 0.80)), BMI (0.50 (0.42, 0.60)) and WC (0.72 (0.63, 0.83)). No interaction was observed between adiposity status, telomere length and mortality. CONCLUSIONS: Obesity is associated with shorter telomere length in young participants, a relationship that diminishes with increasing age. It does not moderate the relationship with mortality.
INTRODUCTION
Excess adiposity is associated with an increased risk of medical comorbidity, 1 frailty, 2 institutionalization 3 and premature death. 4 One potential mechanism that explains these relationships is a pro-inflammatory state that is observed in both the aging process and in the presence of adiposity. 5, 6 It has been hypothesized that the synergistic interplay between aging and adiposity leads to biological and phenotypic impairments such as inflammatory burden and disability, respectively, in this population of older individuals with obesity.
Obesity-associated adipokines and pro-inflammatory cytokines, including interleukin-6 and tumor necrosis factor-α, are believed to directly lead to oxidative damage to DNA. 5, 6 Telomere segments are non-transcriptional segments of DNA that protect chromosomes from degradation. Yet, telomeres themselves are not invulnerable to such damage, leading to their shortening, which is known to be inversely related to longevity and the aging process. Shorter telomeres are associated with an increased risk of developing heart failure, 7 osteoporosis 8 and dementia, 9 and interventions targeting the management of these underlying disease states have the potential to halt shortening and increase survival.
Both body mass index (BMI) and shorter telomere lengths have also independently observed to be related to mortality. benefit is observed with higher BMI, a phenomenon termed 'obesity paradox. 14 Whether an obesity paradox is observed in older adults with different telomere status is unknown. Such information could provide important information as a biomarker in individuals with obesity that could predict long-term mortality. We hypothesized that telomere length was inversely associated with body-fat (BF)-defined adiposity, and determined whether it impacted mortality in a large-scale cohort of US adults.
MATERIALS AND METHODS

Study design and population
For this secondary analysis of data, we utilized the 1999-2002 National Health and Nutrition Examination Surveys (NHANES). This cross-sectional survey has been conducted and managed by the Centers for Disease Control since 1971. The survey contents and procedure manuals are available for online access at http://www.cdc.gov/nchs/nhanes.htm (accessed July 2016). The survey oversamples specific groups (race/ethnic minorities and older adults) and uses a multistage, complex, stratified probability sampling design making it representative of the noninstitutionalized adult population of the United States. This study was exempt from Institutional Review Board review due to the de-identified nature of the data being analyzed.
Subjects were screened, interviewed and ultimately examined in a mobile examination center by a licensed physician and staff (n = 22 133). Persons aged o18 years (n = 6262) were excluded, in addition to individuals without body composition measures (see below) or telomere data (n = 8044). Our final analytical cohort consisted of 7827 adults.
Measures of obesity
Obesity was classified using three methods as the diagnostic accuracy of standard anthropometric measurements differ than gold standard methodologies: BMI; waist circumference (WC); and BF percentage. BMI was calculated as weight (in kilograms) divided by height (in meters) squared. Weight was measured using a calibrated electronic digital scale, and height was measured after deep inhalation using a stadiometer. Subjects were classified using standard BMI categories (underweight ⩽ 18.5 kg m − 2 ; normal 18.5-24.9 kg m − 2 ; overweight 25.0 − 29.9 kg m − 2 ; obesity ⩾ 30 kg m − 2 ). WC was measured in centimeters by trained staff measured standing using a tape measure around the trunk, at the iliac crest, crossing at the mid-axillary line. Measurements were all taken on the right side of the body unless amputations, casts or other factors prevented this from occurring. All body composition measures were assessed using dual-energy X-ray absorptiometry (Hologic Scanner, QDR-4500, Bedford, MA, USA), a procedure lasting 3 min. Exclusion criteria consisted of height ⩾ 192.5 cm, weight ⩾ 136.4 kg or any individual with a procedural contraindication. All metal objects were removed (except false teeth or hearing aids). High-percent BF was categorized using sex-specific cutpoints used in our previous studies (males ⩾ 25%; females ⩾ 35%), 15, 16 but also using ⩾ 28% in men and ⩾ 38% in females.
Telomere data Blood samples were collected by standard protocol. The telomere length assay was performed using PCR at the University of California, San Francisco. Telomere length relative to standard reference DNA (T/S) ratio was measured, with each sample assayed three times on 3 different days, on duplicate wells (six data points). Full details are available at http://cdc. gov/nchs/nhanes under the laboratory section. The interassay coefficient of variation was 6.5%. Values represent the mean (s.d.) of the T/S ratio.
Covariates
A self-reported questionnaire assessed race, smoking status (current, former and never) and comorbid conditions (Have you ever been told by a doctor that you had (medical problem)?). Subjects completed all answers or if they were unable to, their caregiver completed the questions in either English or in Spanish. Age was self-reported from the initial screening questionnaire and subsequently verified against an age verification chart, with differences reconciled using a standard protocol. Age was also categorized as performed in previous analyses and as outlined by the NHANES sampling domains (https://www.cdc.gov/nchs/data/series /sr_02/ sr02_160.pdf; 18-60, 60-69.9, 70-79.9 and ⩾ 80 years). Physical activity was categorized in four levels (sits, walks, light loads and heavy work) using a self-reported questionnaire that asked participants 'Please tell me which of these four sentences best describes your usual daily activities (sits: sits during the day and does not walk about very much; walks: stand or walk about a lot during the day but does not have to carry or lift things very often; light loads: lifts a light load or has to climb stairs or hills often; heavy work: does heavy work or carries heavy loads'.
Mortality data
Mortality data were obtained from the National Death Index, linked to the NHANES data using a unique study identifier. The 2015 public use-linked mortality file was current from time of the mobile examination center evaluation through 31 December 2011. Full details are available at https:// www.cdc.gov/nchs/ndi/index.htm. Time to death was calculated in days from the examination date of death.
Statistical analyses
All data were merged into a single data set according to NHANES protocols. Data were weighted and primary sampling unit and stratum were accounted for in the analysis. Continuous variables are presented as means ± s.e.'s, and categorical variables as counts (percent). A t-test and χ 2 compared continuous and categorical variables. For multilevel variables, an analysis of variance was performed. Age was stratified by age ⩾ 60 and o60 years, and by o70 and ⩾ 70 years to reflect the changes observed in body composition observed with the aging process. [17] [18] [19] Elevated BF was categorized by sex (BF1%: males ⩾ 25%; females ⩾ 35%; BF2%: males ⩾ 28%; females ⩾ 38%) as was WC (males ⩾ 102 cm; females ⩾ 88 cm). Unpaired t-tests compared telomere length between young and older individuals (age o 60 vs ⩾ 60; and age o 70 vs ⩾ 70 years) and as an exploratory analysis among age categories (age 60-69.9, 70-79.9 and ⩾ 80 years) for high/low adiposity measure (BF, BMI and WC). Overall mortality rates were also assessed.
Our primary outcome was to ascertain the association between each body composition measure (predictor) and telomere length (outcome). Separate models were created for each BF definition (referent = low), BMI (referent = normal) and WC (referent = low). Each adiposity measure was also assessed as a continuous variable. β-coefficients ± s.e.'s with associated P-values are presented. Model was 1 was unadjusted; model 2 was adjusted for age, race, education and smoking; and model 3 was further adjusted for diabetes mellitus, congestive heart failure, non-skin cancer, coronary artery disease, arthritis, physical activity and smoking status. Interactions between age category (cutpoint of 60 or 70 years) and each adiposity measure (BF1%, BF2%, BMI or WC) were assessed. We created Cox proportional hazard models to separately assess the risk of death by adiposity measure, telomere length (TL) and death. A separate model assessed telomere length and mortality with a telomere * adiposity category interaction term. We also stratified by age with a similar interaction term. As an ancillary analysis, separate interaction terms for age category * telomere length was assessed within each adiposity category (high vs low). All analyses were performed using STATA v.13 (College Station, TX, USA). A P-value o 0.05 was considered statistically significant.
RESULTS
We identified 7827 individuals who met our inclusion criteria that were part of the analytical cohort. Baseline characteristics are represented in Table 1 . Mean age was 46.1 ± 0.37 years (51.4% female). Differences were observed in race, comorbidity, smoking status, physical activity level and BF and WC. Telomere length was 1.05 ± 0.01 in the overall cohort but was shorter in the older compared to the younger cohorts (o 60 years: 0.91 ± 0.02 vs 1.10 ± 0.01; Po 0.001; age 70 years: 0.87 ± 0.02 vs 1.08 ± 0.01; P o0.001). Telomere length was higher in younger participants independent of BF status. In older adults, telomere length shortened between ages 60-69.9, 70-79.9 and ⩾ 80 years in the overall cohort (0.96 ± 0.02, 0.88 ± 0.02 and 0.84 ± 0.02; P o0.001). This decrease in telomere length with age was also observed across BF and WC categories ( Table 2) .
We observed consistent relationships with additional covariate adjustment (Table 3) . High BF1% or BF2% and WC were strongly associated with lower telomere length (β = − 0.035 ± 0.011, P = 0.002; β = − 0.041 ± 0.008, P o 0.001; and β = − 0.032 ± 0.011, P = 0.008). Testing the interactive effect between BF, BMI and WC as continuous variables with age on telomere length demonstrated P-values of o 0.001, o0.001 and 0.007, respectively. High BF, BMI-obesity and high WC were all inversely associated with telomere length (Table 4) , a trend that dissipated with increasing age. The analysis was subsequently stratified by age and suggested that adiposity is associated with reduced telomere length but disappears with increasing age. This is most clear with BF% and less clear for BMI and WC. Mortality rates are presented in Supplementary Appendix 1. Multivariable mortality analyses of age category, telomere length and mortality are noted in Table 5 . High BF, BMI and WC were protective in older adults but led to a higher mortality risk in younger adults. TL was inversely associated with mortality risk in older adults. We did not observe an interaction between adiposity category, telomere length and mortality. This was also not observed between high/low age categories. Our ancillary analyses (Supplementary Appendices 2 and 3) demonstrate that in low-adiposity categories there is an interaction between telomere length and age on mortality.
DISCUSSION
With an increased interest in the contribution of telomere length in the aging process, this study suggests an inverse association between shorter telomere length and increased adiposity. However, our mortality results suggest that with increasing age, there is an attenuation in the association of adiposity on TL and mortality. The results also imply that among the very old, for those with obesity, irrespective of how it is defined, telomere length compared to individuals with normal body composition may not have a significant impact on important outcomes.
We observed a consistent inverse relationship between high BF and WC on length of telomeres in the entire adult population examined. Our results may provide biological insight to the associations of both BF and WC with disability and mortality in large, population-based studies. 20, 21 When our analyses were stratified by age, the association between adiposity and telomere length was only observed in younger adults and diminished in older adults. A few potential explanations could exist. First, ageassociated body composition changes (fat and muscle) between the ages 60 and 70 may impact peripheral blood telomere length, and could provide some potential mechanistic explanation to our findings. Whether and how adipose tissue modifies the effect of telomere repair mechanisms, for example, reduced expression of telomerase, 22, 23 is unclear but could have a role. Our results may parallel the findings, in part, to those of Bischoff et al. 24 who found that with increasing age, the relationship between telomere length and age lessened, yet contrasts to the findings by Lee et al. 25 Only with longitudinal data could the relationship between adiposity and telomere length be confirmed. As such, our findings should be considered exploratory.
The cross-sectional associations and mortality estimates became nonsignificant in older adults, a phenomenon that has been observed with the obesity paradox in certain populations, 14 where obesity can be 'protective' on longer-term outcomes in older adults. By deliberately stratifying by age, we assessed the relationship of telomere length with aging. Telomere length in younger individuals with obesity is lower, suggesting a higher-risk population. Yet, this relationship appears to be nonsignificant across all older age groups. We evaluated the interaction of adiposity on telomere length on mortality and found that it did not modify its risk. In older adults with adiposity, there appeared to be a protective effect of adiposity on death, results that were nonsignificant after incorporating telomere length in the analysis. Those with adiposity may have died earlier and those remaining in older age may have had a slower rate of accumulation of subcutaneous and visceral adiposity, both of which can have a negative impact on telomere length. Previous studies have demonstrated that duration of adiposity is a negative prognostic factor in health outcomes. 26 In certain individuals, this shorter timeframe prevents the accumulation of inflammatory and comorbid factors that could contribute to disease. Factors such as fat-free mass, nutritional status or cardiorespiratory fitness may also have a role. These findings can add to the growing and disparate literature of how obesity can potentially moderate telomere length through inflammatory and oxidative stress mechanisms. A possible hypothesis to explain the lack of association between adiposity and TL on mortality in the oldest old is that accumulated exposures from obesity (for example, cardiometabolic, musculoskeletal or organ-specific harms) could plateau and not result in additional problems. Senescence could be prematurely triggered by obesity. [27] [28] [29] In vitro studies have demonstrated that weight changes may be implicated in this process as well. Adipose tissue changes with age, which may reflect underlying genetic changes, and hence telomere alterations. Future work should focus on understanding more thoroughly these mechanistic changes as it has implications on other telomere-related diseases of aging.
The multivariable modeling deliberately adjusted for a number of sociodemographic and comorbidities that could impact both ). High waist circumference is categorized in males as ⩾ 102 cm in males and ⩾ 88 cm in females. a P-value represents difference in telomere length between individuals aged o60 and 460 years.
b P-value represents the difference between high/low body fat, BMI or waist circumference within the overall cohort, and stratified by age 60. obesity and telomere lengthening. After model adjustment, the strength of association did not markedly change. These findings implicate high adiposity and possible adipokines could be the main toxic exposure impacting telomere length. We would have expected that the relationship would weaken our estimates after adding covariates representing inflammatory mediators yet the data set did not have such information. Other pro-inflammatory and/or lipid-mediating hormones that were unmeasured likely influence this relationship. 30 The relationship between adiposeassociated factors such as the adipokines leptin and adiponectin with telomere length or telomerase activity is not entirely clear. Similar positive associations were observed between telomere length and insulin-like growth factor in a study of elderly men. 31 Another cross-sectional study found no significant association between telomere activity and adiposity, BMI, visceral fat, adiponectin or leptin in a smaller cohort of healthy adults (n = 317, age 40-64) recruited from a health center. 30 The one prospective study that has reported telomere length change over time among individuals with stable coronary disease, demonstrated three trajectories of individuals whose leukocyte telomere length shortened, lengthened or remained stable. 32 Abdominal obesity (waist-hip ratio) was independently predictive of increased risk of shorter telomeres over a 5-year follow-up, along with the other independent predictors, baseline telomere length, age and male sex, even when controlling for BMI, adipokines (adiponectin and leptin) and inflammatory markers (C-reactive, interleukin-6 and tumor necrosis factor-α). Thus, specific strata such as sex or age, as demonstrated in the current study, may influence associations and explain discrepant findings when analyses do not account for these moderators.
The results from a recent systematic review and meta-analysis demonstrated that the association between telomere length and BMI was weak to moderate in nature. 12, 13 Our study indicated that the standard BMI categories were not related to telomere length and did not impact risk of death. A potential explanation could be that BMI is known to be a poor marker of general adiposity, missing 50% of those with obesity in a general population 33 but also having a poor sensitivity in an older population. 34 This ubiquitous measure incorporates both fat and muscle mass, while dual-energy X-ray absorptiometry-measured BF ascertains overall fat mass, and WC is a surrogate for central adiposity. Our results may explain the inconsistent results observed with relationships between adiposity and telomere length, when using BMI as a surrogate for adiposity, as described by An et al. 35 and Njajou et al.
36
A disadvantage of categorizing a continuous variable into categories is not only the loss of study power, but values slightly above the threshold may have only incremental and modest longterm risk, potentially resulting in overdiagnosis. 37 Misclassification is possible as well, and this has implications for public health in the identification and the management of higher-risk populations. We deliberately used each of these anthropometric measures in our modeling as a continuous variable to circumvent this issue and to demonstrate that our results were consistent.
The study has a number of limitations inherent to NHANES such as the use of community-dwelling adults and self-reported bias. As older adulthood generally is considered 65 years and older, we deliberately created two dichotomous cutpoints to assess changes in these age groups; however, we recognize that our sample size in those aged ⩾ 70 years may limit our ability to make generalizations. Other biomarkers, including inflammatory cytokines could be helpful to explain this phenomenon between increased adiposity and decreased telomere length, and their interplay should be considered in further studies. Lifespan changes of adiposity are not accounted for in this analysis, including weight change and weight cycling. Importantly, alterations in physical function that could impact morbidity, mortality and quality of life should be considered. 
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Implications
In an era of individualized medicine, our results provide some helpful guidance for clinical practice. First, using telomere length to predict outcomes on disease states in populations with obesity may only reveal associations in younger as compared to older adults. Second, the use of biological data in obesity medicine, while still in its infancy, may explain a number of the relationships that are observed in large-scale epidemiological studies. This translational approach can help clarify relationships that are inconclusive. Third, our results further suggest the need to move away from traditional measures of adiposity (that is, BMI) and move toward BF percent, which has increased ability to predict long-term outcomes. In low-tech settings, at least WC or waist-hip ratio should be considered. Fourth, our results provide evidence for an independent effect of obesity on telomere length specifically in younger adults. Yet, we did not observe any interactive effects, specifically in older adults. Engaging in healthy lifestyle measures improves one's chances of preventing disability, 38 enhancing quality of life and reducing disease burden, all important tenants in old age. Yet, our results prompt the need for further evaluation of longitudinal data sets with repeated measures to assess whether reduced adiposity in earlier geriatric years can restore telomerase activity, and thus telomere length. This reversal may be beneficial in this population.
CONCLUSIONS
Shorter telomere length is inversely related to higher-percent BF and WC but becomes nonsignificant in adults over the age of 60 years. Adiposity does not appear to modify the relationship between telomere length and mortality in community-dwelling adults. ).
